PROCEPT BioRobotics Corporation Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PROCEPT BioRobotics Corporation stock issued during period, value, conversion of convertible securities for the quarter ending 2021-09-30 was $329.53M, a 3361.49% increase year-over-year.
- PROCEPT BioRobotics Corporation stock issued during period, value, conversion of convertible securities for the quarter ending 2020-09-30 was $9.52M.
- PROCEPT BioRobotics Corporation stock issued during period, value, conversion of convertible securities for fiscal 2021 was $329.53M, a 3361.49% increase from fiscal 2020.
- PROCEPT BioRobotics Corporation stock issued during period, value, conversion of convertible securities for fiscal 2020 was $9.52M.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2021-12-31 | $329.53M 10-K · filed 2024-02-28 | |
| 2021-09-30 | $329.53M 10-Q · filed 2022-11-04 | |
| 2020-12-31 | $9.52M 10-K · filed 2022-03-22 | |
| 2020-09-30 | $9.52M 10-Q · filed 2021-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |